Eagle Pharmaceuticals Inc (EGRX)
3.85
+0.03
(+0.79%)
USD |
NASDAQ |
Jun 14, 16:00
3.83
-0.02
(-0.52%)
After-Hours: 20:00
Eagle Pharmaceuticals Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 104.84M |
| June 13, 2024 | 104.45M |
| June 12, 2024 | 102.50M |
| June 11, 2024 | 102.63M |
| June 10, 2024 | 101.07M |
| June 07, 2024 | 103.02M |
| June 06, 2024 | 103.28M |
| June 05, 2024 | 106.79M |
| June 04, 2024 | 100.81M |
| June 03, 2024 | 104.32M |
| May 31, 2024 | 99.90M |
| May 30, 2024 | 99.32M |
| May 29, 2024 | 98.22M |
| May 28, 2024 | 105.75M |
| May 24, 2024 | 103.41M |
| May 23, 2024 | 103.28M |
| May 22, 2024 | 104.32M |
| May 21, 2024 | 111.59M |
| May 20, 2024 | 114.71M |
| May 17, 2024 | 116.66M |
| May 16, 2024 | 116.53M |
| May 15, 2024 | 114.71M |
| May 14, 2024 | 115.49M |
| May 13, 2024 | 113.28M |
| May 10, 2024 | 113.80M |
| Date | Value |
|---|---|
| May 09, 2024 | 115.36M |
| May 08, 2024 | 116.53M |
| May 07, 2024 | 116.53M |
| May 06, 2024 | 114.19M |
| May 03, 2024 | 112.11M |
| May 02, 2024 | 111.98M |
| May 01, 2024 | 109.25M |
| April 30, 2024 | 107.96M |
| April 29, 2024 | 107.44M |
| April 26, 2024 | 108.86M |
| April 25, 2024 | 109.90M |
| April 24, 2024 | 113.93M |
| April 23, 2024 | 116.79M |
| April 22, 2024 | 113.93M |
| April 19, 2024 | 114.71M |
| April 18, 2024 | 113.02M |
| April 17, 2024 | 111.85M |
| April 16, 2024 | 115.75M |
| April 15, 2024 | 122.37M |
| April 12, 2024 | 114.45M |
| April 11, 2024 | 116.79M |
| April 10, 2024 | 115.88M |
| April 09, 2024 | 119.12M |
| April 08, 2024 | 119.77M |
| April 05, 2024 | 121.33M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
98.22M
Minimum
May 29 2024
801.67M
Maximum
Nov 01 2019
477.12M
Average
518.70M
Median
Enterprise Value Benchmarks
| Baxter International Inc | 27.98B |
| Soligenix Inc | -0.0862M |
| Aldeyra Therapeutics Inc | 103.78M |
| Marinus Pharmaceuticals Inc | 40.70M |
| BioXcel Therapeutics Inc | 78.91M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 5.164M |
| Revenue (Quarterly) | 64.65M |
| Total Expenses (Quarterly) | 54.34M |
| EPS Diluted (Quarterly) | 0.39 |